Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.
Location: Denmark, Capital Region of Denmark, Copenhagen
Member count: 11-50
Total raised: $190M
Founded date: 2019
Investors 3
| Date | Name | Website |
| 23.03.2023 | Avoro Capi... | avorocapit... |
| 15.03.2023 | Access Bio... | accessbio-... |
| - | RA Capital... | racap.com |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 22.02.2023 | Series B | $135M | - | finsmes.co... |
| 22.07.2021 | Series A | $55M | Novo Holdi... | finsmes.co... |
Mentions in press and media 10
| Date | Title | Description | Category | Author | Source |
| 03.03.2023 | Hemab Ther... | COPENHAGEN, Demark and BOSTON,... | - | - | healthcap.... |
| 22.02.2023 | HealthCap ... | HealthCap VIII portfolio compa... | - | - | healthcap.... |
| 21.02.2023 | Hemab Ther... | Hemab Therapeutics, a Copenhag... | Denmark U... | - | finsmes.co... |
| 11.01.2023 | Hemab Ther... | Bispecific antibody HMB-001 po... | - | - | healthcap.... |
| 12.01.2022 | Hemab Ther... | Experts in clinical developmen... | - | - | healthcap.... |
| 22.07.2021 | Hemab Rais... | Hemab ApS, a Copenhagen, Denma... | Denmark | - | finsmes.co... |
| 22.07.2021 | Hemab rais... | Hemab has raised $55 million t... | Biotech | - | fiercebiot... |
| - | Successful... | Copenhagen, Denmark and Boston... | - | - | healthcap.... |
| - | Hemab Appo... | Copenhagen, Denmark and Boston... | - | - | healthcap.... |
| - | Hemab | “Hemab is pioneering the first... | - | - | fastfounde... |